After missing out on FDA voucher, bluebird quickly raises funds to ...
WEBDec 19, 2023 · Now, bluebird is hurrying to raise millions of dollars—through two separate avenues—to fund the launch of its new sickle cell disease gene therapy and others.
press releases - bluebird bio, Inc.
WEBSep 13, 2024 · SOMERVILLE, Mass. --(BUSINESS WIRE)--Sep. 13, 2024-- bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has completed the restatement of its consolidated financial statements for the year ended December 31, 2022 , and for each of the first three quarters of 2022 and 2023.
Bluebird's $2.8 million gene therapy becomes most expensive …
WEBAug 18, 2022 · Aug 17 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved bluebird bio's (BLUE.O) gene therapy for patients with a rare disorder requiring regular blood transfusions, and the...
UPDATED: Bluebird’s sickle cell gene therapy comes with safety …
WEBDec 8, 2023 · Bluebird touts Zynteglo, Skysona launch progress as FDA decision on sickle cell therapy nears. While struggling on the financial front, bluebird has one advantage in Lyfgenia’s favor. Because...
bluebird's (BLUE) Gene Therapy Approvals to Drive the Top Line
WEBOct 3, 2022 · bluebird's (BLUE) recent FDA approvals for its gene therapies, namely beta-cel for beta-thalassemia and eli-cel for cerebral adrenoleukodystrophy, are expected to drive the top line.
bluebird bio Announces FDA Approval of LYFGENIA™ …
WEBDec 8, 2023 · Patients treated with LYFGENIA in bluebird bio-sponsored clinical studies will be monitored for a total of 15 years through a long-term safety and efficacy follow-up study (LTF-307). Conference...
Bluebirds are back from the brink thanks to human interventions
WEBMay 2, 2023 · The eastern bluebird population was once in rapid decline because of a perfect storm of factors, but today their population has recovered well and these birds are a common sight once again.
First Patient Begins Newly Approved Sickle Cell Gene Therapy
WEBMay 6, 2024 · Kendric Cromer, 12, the first commercial patient for Bluebird Bio’s gene therapy to cure his sickle cell disease, in the hospital as his bone marrow stem cells were being removed for gene editing.
North American Bluebird Society
WEBThe North American Bluebird Society is a non-profit education, conservation and research organization that promotes the recovery of bluebirds and other native cavity-nesting bird species in North America. (Read more below.) Fact Sheets, Plans, and Handouts.
bluebird bio gains FDA approval of gene therapy lovo-cel for ... - MSN
WEBThe U.S. FDA Friday approved bluebird bio's (NASDAQ: BLUE) Lyfgenia (lovo-cel), a gene therapy for sickle cell disease. The treatment uses a lentiviral vector -- a type of gene delivery vehicle...